CCND1 and nonpapillary renal cell carcinoma: Using the data from gene expression profiling interactive analysis (GEPIA), we noted that ccRCC patients who had an association of genomic alterations in CCND1 showed reductions in overall and disease-free survival (P=2.5E-05 for overall survival and P=6.7E-05 for disease-free survival) (Figure 3A–3B).